Home / Media Centre / Company News / PJSC SIC “BCPP” STARTED PRODUCTION OF THE NEW PRODUCT MIRAXOL
12.10.2012
PJSC SIC “BCPP” STARTED PRODUCTION OF THE NEW PRODUCT MIRAXOL
Therapeutic indications.
Idiopathic Parkinson's disease (as monotherapy or in combination with levodopa). Symptomatic treatment of idiopathic restless legs syndrome.
-
12.10.2012
PARTICIPATION IN CPHI WORLDWIDE 2012, MADRID
-
02.09.2012
PJSC SIC “BCPP” STARTED PRODUCTION OF THE NEW PRODUCT MONTEL
-
26.07.2012
PJSC SIC “BCPP” STARTED PRODUCTION OF THE NEW PRODUCT TAMSULID